Prolyl-leucyl-glycinamide, thyrotropin-releasing hormone and beta-endorphin-(10-16), like antidepressants, antagonize melatonin-induced behavioural changes in rats.
beta-Endorphin-(10-16), as well as a variety of antidepressants, has been reported to block the behavioural changes induced by injecting melatonin into the nucleus accumbens. In the present study the influence of subcutaneously administered prolyl-leucyl-glycinamide (PLG) and thyrotropin-releasing hormone (TRH) on the behavioural changes induced by melatonin administration in the nucleus accumbens were investigated and compared with that of beta-endorphin-(10-16). PLG and TRH were found to be as effective as beta-endorphin-(10-16) in counteracting the melatonin-induced behavioural changes. The data suggest that these peptides may serve as a starting point for the development of a new class of antidepressants.